News for Hutchison China MediTech Limited (HCM.L)

Medical services provider Zhongchao Inc. (ZCMD) saw its stock rise by over 5%, reaching $2.52. This increase highlights investor interest in the company, despit

May 11, 2021 / 12:00PM GMTAlec Warren Stranahan - BofA Securities, Research Division - Associate Hey, everyone, good morning, and welcome to Day 2 of BofA Healt

Mar 04, 2021 / 01:00PM GMTChristian Hogg - Hutchison China MediTech Limited - CEO & Executive Director Okay. Thank you. This is Christian Hogg, CEO of HUTCHMED.

Jan 11, 2021 / 01:00PM GMTDavid Lau - JPMorgan Chase & Co. - Head of China Investment Banking Coverage Good morning, everyone. My name is David Lau from JPMorga

May 14, 2020 / 01:40PM GMTAlec Warren Stranahan - BofA Merrill Lynch, Research Division - Associate Hello everyone. Welcome to the final day of the 2020 Bank of

Jan 15, 2020 / 09:00PM GMTXiao Yu Li - JP Morgan Chase & Co, Research Division - Analyst Okay. Good afternoon, everyone. I'm David Li from JPMorgan Equity Resea

Sep 30, 2019 / 12:00PM GMTChristian Hogg - Hutchison China MediTech Limited - CEO & Executive Director Welcome, everybody, to the ESMO conference call in which

Sep 11, 2019 / 01:55PM GMTMatthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director Great. So good morning, everybody. Thanks for joining

Jul 30, 2019 / 08:00AM GMTPresentationJul 30, 2019 / 08:00AM GMT =====================Corporate Participants===================== * Christian Hogg Hutch

Mar 11, 2019 / 01:00PM GMTOperator Hello, and welcome to the Chi-Med 2018 Full Year Financial Results. My name is Molly, and I'll be your coordinator for today'

U.S. securities regulator says Hutchmed is one of five Chinese companies in danger of delisting, a week after company announced the retirement of its longtime CEO. Read more here.

Cholangiocarcinoma Pipeline is majorly witnessing TAS-120, AG-120, E7090, and E7090 as the most anticipating therapies.

The following slide deck was published by Hutchison China MediTech Limited in conjunction with their 2020 Q4 earnings call.

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited ("Chi-Med") (Nasdaq/AIM: HCM) today announces ...

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (Nasdaq/AIM: HCM) tod...